SyntheticMR Announces the Appointment of Francois Hebert as New President, North America

LINKÖPING, Sweden , Sept. 4, 2024 /PRNewswire/ — SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of SyntheticMR, North America. With three decades of experience in healthcare and medical imaging, Frank brings extensive expertise from his recent senior leadership roles.

“I am thrilled to join SyntheticMR, a company at the forefront of medical imaging innovation. My focus will be on accelerating our mission to transform patient care through our unique technology and provide radiologists with decision support solutions and essential quantitative data, with the goal of making SyMRI the standard of care in magnetic resonance imaging,” said Frank.

Frank has an outstanding track record of leadership and success in the field, having held various senior management positions where he outstandingly contributed to advancements in technology and business growth. His previous roles include significant leadership positions at Lemer Pax America, Hermes Medical Solutions, Rhapsody, and Biodex Medical Systems, underscoring his deep understanding of medical technology and strategic business development both domestically and globally.

As President, Frank Hebert will oversee all operational aspects of SyntheticMR in North America, focusing on expanding our market reach and enhancing product offerings to meet the evolving needs of our customers. His leadership is anticipated to invigorate our team and fortify our position as a leader in the development of cutting-edge imaging technologies.

“Frank brings an extraordinary array of skills and deep experience that will be critical to drive our company’s vision forward. We are excited to see how his leadership will propel SyntheticMR, North America into a new era of innovation and growth,” says Ulrik Harrysson, CEO of SyntheticMR.

Frank’s appointment is a strategic move for SyntheticMR, aiming to enhance its market presence and innovation in North America.

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com or Francois Hebert, President, SyntheticMR, North America: +1 514 779-8215 frank.hebert@syntheticmr.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/syntheticmr-ab/r/syntheticmr-announces-the-appointment-of-francois-hebert-as-new-president–north-america,c4032556

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/syntheticmr-announces-the-appointment-of-francois-hebert-as-new-president-north-america-302237759.html

SOURCE SyntheticMR AB

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

17 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

17 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

17 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

17 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

17 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

17 hours ago